Filtros de búsqueda

Lista de obras de David I Quinn

A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma

scientific article published on 14 June 2007

A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer

artículo científico publicado en 2014

A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors.

artículo científico publicado en 2013

A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

artículo científico publicado en 2011

A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer

artículo científico publicado en 2008

A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma.

artículo científico publicado en 2011

A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer

artículo científico publicado en 2003

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.

artículo científico publicado en 2014

A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases

artículo científico publicado en 2006

Active Surveillance for Prostate Cancer: Are We Failing Latino Patients at a Large Safety Net Hospital?

artículo científico publicado en 2018

Acute renal impairment after immersion and near-drowning.

artículo científico publicado en 1999

Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.

artículo científico publicado en 2008

Adverse drug reactions and their measurement in the rheumatic diseases

artículo científico publicado en 1995

Adverse interaction between warfarin and indomethacin

artículo científico publicado en 1994

Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer

artículo científico publicado en 2001

An audit of oestrogen implant hormone replacement therapy

artículo científico publicado en 1998

Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival

scientific article published on 01 June 2018

Association of overall survival with glycolytic activity of castrate-resistant prostate cancer metastases

artículo científico publicado en 2015

Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer.

artículo científico publicado en 2013

Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer

artículo científico publicado en 2017

Blood cells and their use in active immunotherapy of prostate cancer.

artículo científico publicado en 2012

Bortezomib plus docetaxel in advanced non-small cell lung cancer and other solid tumors: a phase I California Cancer Consortium trial.

artículo científico publicado en 2006

Cabazitaxel in prostate cancer: stretching a string

artículo científico publicado en 2010

Carboplatin's fourth decade: still searching for its sweet spot

artículo científico publicado en 2014

Chromoplexy and hypoxic microenvironment drives prostate cancer

artículo científico publicado en 2014

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Metastatic Genitourinary Cancer Patients

artículo científico publicado en 2020

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.

artículo científico publicado en 2014

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial

artículo científico publicado en 2014

Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer

artículo científico publicado en 2010

Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology

artículo científico publicado en 2012

Comparative effectiveness of screening strategies for colorectal cancer.

artículo científico publicado en 2017

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.

artículo científico publicado en 2014

Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue

scientific article published on 01 October 1999

Differentiating mTOR inhibitors in renal cell carcinoma

artículo científico publicado en 2013

Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines

artículo científico publicado en 2005

Dissecting the rugby tackle: do shoulder pads contribute to cervical spine injuries?

artículo científico publicado en 1998

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

artículo científico publicado en 2013

Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer

artículo científico publicado en 2011

Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression

artículo científico publicado en 2003

Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal

artículo científico publicado en 2013

Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.

artículo científico publicado en 2013

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations

artículo científico publicado en 2018

Efficacy of oxaliplatin plus pemetrexed in chemotherapy pretreated metastatic castration-resistant prostate cancer

artículo científico publicado en 2013

Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer

artículo científico publicado en 1999

EphB4 expression and biological significance in prostate cancer

artículo científico publicado en 2005

EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.

artículo científico publicado en 2006

Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases

artículo científico publicado en 2013

Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States.

artículo científico publicado en 2014

Experience with sorafenib and adverse event management.

artículo científico publicado en 2010

Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.

artículo científico publicado en 2006

Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer

artículo científico publicado en 2006

Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.

artículo científico publicado en 2003

Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.

artículo científico publicado en 2011

Fasting and cancer treatment in humans: A case series report.

artículo científico publicado en 2009

Frequent loss of estrogen receptor-beta expression in prostate cancer.

artículo científico publicado en 2001

Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40.

artículo científico publicado en 1998

Hazards of low dose methotrexate

artículo científico publicado en 1995

Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.

artículo científico publicado en 2004

Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial

artículo científico publicado en 2014

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.

artículo científico publicado en 2012

Immune response to sipuleucel-T in prostate cancer

artículo científico publicado en 2012

Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib

scientific article published on 23 September 2019

Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study.

artículo científico publicado en 2007

International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

artículo científico publicado en 2002

Is year of radical prostatectomy a predictor of outcome in prostate cancer?

scientific article published on 01 February 2004

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

artículo científico publicado en 2003

Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

artículo científico publicado en 2015

Microscopic and gross extravesical extension in pathological staging of bladder cancer

artículo científico publicado en 2004

Molecular prognostication in bladder cancer--a current perspective.

artículo científico publicado en 2003

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma ⬇️

artículo científico publicado el 4 de junio de 2012

Natural history of surgically treated bladder carcinoma with extravesical tumor extension.

artículo científico publicado en 2003

Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California

artículo científico publicado en 2012

Non-steroidal anti-inflammatory drugs

artículo científico publicado en 1995

Novel Therapies for Metastatic Renal Cell Carcinoma: Efforts to Expand beyond the VEGF/mTOR Signaling Paradigm ⬇️

artículo científico publicado el 17 de febrero de 2012

Novel tyrosine kinase inhibitors for renal cell carcinoma.

artículo científico publicado en 2013

Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium.

artículo científico publicado en 2007

One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer

artículo científico publicado en 2015

One-year follow-up of collaborative depression care for low-income, predominantly Hispanic patients with cancer

artículo científico publicado en 2011

Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial

artículo científico publicado en 2009

Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients

artículo científico publicado en 2001

Perioperative chemotherapy for urothelial cancer: how have we made a "sow's ear" out of a chemotherapy-sensitive tumor?

artículo científico publicado en 2009

Pharmacokinetic and Pharmacodynamic Principles of Illicit Drug Use and Treatment of Illicit Drug Users

artículo científico publicado el 1 de noviembre de 1997

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

artículo científico publicado en 2014

Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumors

artículo científico publicado en 2011

Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors

artículo científico publicado en 2014

Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis

artículo científico publicado en 2006

Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy

artículo científico publicado en 2006

Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancer

artículo científico publicado en 2014

Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317.

artículo científico publicado en 2009

Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879

artículo científico publicado en 2021

Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder.

artículo científico publicado en 2008

Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastases

artículo científico publicado en 2005

Postchemotherapy residual masses in advanced seminoma: current management and outcomes.

artículo científico publicado en 2005

Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy

scientific article published on 01 March 2000

Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models

scientific article published on 01 August 2001

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion

artículo científico publicado en 2003

Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression.

artículo científico publicado en 2014

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer

artículo científico publicado en 2012

Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis

artículo científico publicado en 2015

Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis

artículo científico publicado en 1993

Randomized controlled trial of collaborative care management of depression among low-income patients with cancer

artículo científico publicado en 2008

Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study

artículo científico publicado en 2014

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.

artículo científico publicado en 2012

SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.

artículo científico publicado en 2003

SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer

artículo científico publicado en 2015

Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma

artículo científico publicado en 2020

Salvage chemotherapy for refractory germ cell tumors

artículo científico publicado en 2014

Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T.

artículo científico publicado en 2014

Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.

scientific article published on 24 February 2014

Show us a sign: the search for "game changing" prostate cancer biomarkers.

artículo científico publicado en 2011

Small Cell Bladder Cancer: Biology and Management ⬇️

artículo científico publicado el 1 de octubre de 2012

Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.

artículo científico publicado en 2006

Speeding dating for docetaxel and recent debutantes in castration-resistant prostate cancer: 'plus or minus' may be a minus

artículo científico publicado en 2013

Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy

artículo científico publicado en 2008

Surgery and adjunctive chemotherapy for invasive bladder cancer

artículo científico publicado en 2002

Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

artículo científico publicado en 2003

Targeted therapy in renal cancer

artículo científico publicado en 2009

Targeted α-particle therapy of bone metastases in prostate cancer

artículo científico publicado en 2013

The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial

artículo científico publicado en 2007

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

artículo científico publicado en 2008

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.

artículo científico publicado en 2008

The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy

artículo científico publicado en 2005

The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder

artículo científico publicado en 2014

The future in advanced prostate cancer: take your partners or is the last dance for me?

artículo científico publicado en 2004

The role of surrogate markers in the management of men with metastatic castration-resistant prostate cancer.

artículo científico

Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore

artículo científico publicado en 2013

Tinea of the skin, hair and nails

artículo científico publicado en 1996

Tivozanib in the treatment of renal cell carcinoma.

artículo científico publicado en 2013

Up-regulation of EphB4 in mesothelioma and its biological significance

artículo científico publicado en 2005

Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters

scientific article published on 01 September 2020

Using molecular markers to help predict who will fail after radical prostatectomy

artículo científico

Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer.

artículo científico publicado en 2011

Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer

artículo científico publicado en 2002

Zinc-alpha2-glycoprotein Expression as a Predictor of Metastatic Prostate Cancer Following Radical Prostatectomy

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda